Objective: To evaluate the efficacy of Aredia to relieve pain due to metastatic bone tumor.
Methods: Aredia 60-90 mg in 500 ml 5% glucose or normal saline was given by i.v. infusion. The treatment was repeated at 2-4 week intervals.
Results: Complete relief of pain was observed in 9 patients, partial relief in 13 patients. The treatment was of no effect in 3 patients. The therapeutic effect was achieved in 72.7% of the patients within 2 weeks.
Conclusion: Aredia is a good pain reliever in patients with metastatic cancer of the bone.